Tim Sinioja
Title: Doctoral Student School/office: School of Science and TechnologyEmail: tim.sinioja@oru.se
Phone: +46 19 301471
Room: B3105
Research teams
Publications
Articles in journals |
Articles in journals
- Sinioja, T. , Bodin, J. , Duberg, D. , Dirven, H. , Berntsen, H. F. , Zimmer, K. , Nygaard, U. C. , Oresic, M. & et al. (2022). Exposure to persistent organic pollutants alters the serum metabolome in non-obese diabetic mice. Metabolomics, 18 (11).
- Lützhøft, D. O. , Sinioja, T. , Christoffersen, B. Ø. , Jakobsen, R. R. , Geng, D. , Ahmad, H. F. B. , Straarup, E. M. , Pedersen, K. & et al. (2022). Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model. BMC Microbiology, 22 (1).
- Sen, P. , Govaere, O. , Sinioja, T. , McGlinchey, A. J. , Geng, D. , Ratziu, V. , Bugianesi, E. , Schattenberg, J. M. & et al. (2022). Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience, 25 (9).
- Thomas, I. , Dickens, A. M. , Posti, J. P. , Czeiter, E. , Duberg, D. , Sinioja, T. , Kråkström, M. , Retel Helmrich, I. R. A. & et al. (2022). Serum metabolome associated with severity of acute traumatic brain injury. Nature Communications, 13 (1).
- Sen, P. , Govaere, O. , Sinioja, T. , McGlinchey, A. J. , Geng, D. , Ratziu, V. , Bugianesi, E. , Schattenberg, J. & et al. (2021). Genome-scale metabolic modeling of human hepatocytes reveals dysregulation of glycosphingolipid pathways in progressive non-alcoholic fatty liver disease. Journal of Hepatology, 75 (Suppl. 2), S256-S256.
- Schlezinger, J. J. , Hyötyläinen, T. , Sinioja, T. , Boston, C. , Puckett, H. , Oliver, J. , Heiger-Bernays, W. & Webster, T. F. (2021). Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPAR α mice fed an American diet. Toxicology and Applied Pharmacology, 426.
- McGlinchey, A. J. , Sinioja, T. , Lamichhane, S. , Sen, P. , Bodin, J. , Siljander, H. , Dickens, A. M. , Geng, D. & et al. (2020). Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes. Environment International, 143.